Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-19

Clinical Trial Update: Effective Study of Live Attenuated Varicella Vaccine to Treat Severe Resistant Psoriasis [Phase 4]

View source ↗

Summary

A Phase 4 study investigated whether a live attenuated varicella vaccine could treat severe resistant psoriasis and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varicella vaccine, live attenuated (varicella vaccine, live attenuated)

Snippet

Sponsor: Cairo University | Conditions: Psoriasis | Phase 4 | Status: COMPLETED